glutathione mutations in sclc patients Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming EGFR-Mutant Lung Cancer The role of ERBB4 mutations
The role of ERBB4 mutations in the prognosis of advanced non small cell lung cancer treated with immune checkpoint inhibitors Molecular Medicine Springer Nature Link The Era of Antibody Drug Conjugates in Lung Cancer: Trick or Threat? Integrative Analysis of a Large Real World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation PMC Frontiers Molecular subtypes based on ferroptosis related genes and tumor microenvironment infiltration characterization in small cell lung cancer In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



